Compare JAGX & AQB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JAGX | AQB |
|---|---|---|
| Founded | 2013 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9M | 3.9M |
| IPO Year | N/A | N/A |
| Metric | JAGX | AQB |
|---|---|---|
| Price | $1.18 | $0.91 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $60.00 | N/A |
| AVG Volume (30 Days) | ★ 380.3K | 33.1K |
| Earning Date | 11-17-2025 | 10-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $11,785,000.00 | N/A |
| Revenue This Year | $22.41 | N/A |
| Revenue Next Year | $30.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 12.45 | N/A |
| 52 Week Low | $1.00 | $0.47 |
| 52 Week High | $33.25 | $2.95 |
| Indicator | JAGX | AQB |
|---|---|---|
| Relative Strength Index (RSI) | 41.39 | 35.60 |
| Support Level | $1.05 | $0.91 |
| Resistance Level | $1.36 | $1.03 |
| Average True Range (ATR) | 0.16 | 0.07 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 38.00 | 16.81 |
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.
AquaBounty Technologies Inc is engaged in the field of land-based aquaculture and the use of technology to improve the productivity and sustainability. The company's objective is to ensure the availability of high-quality seafood to meet consumer demand while addressing critical production constraints in the popular farmed species.